Cherven B, Castellino SM, Chen Y, et al. - Researchers surveyed cancer survivors (9 to 26 years old) 1 to 5 years following their treatment for their human papillomavirus (HPV) vaccine initiation status, HPV vaccine intent, sociodemographic factors, and vaccine-related health beliefs. From the Georgia Registry for Immunization Transactions, they abstracted HPV vaccine doses/dates for 3.5 years after survey participation. Provider recommendation for the HPV vaccine, a positive general attitude toward vaccines and perceived severity of HPV disease were the factors associated with vaccine intent among survivors who were HPV vaccine–naive at survey participation (n = 103). Initiation of HPV vaccination was observed in 28 of the vaccine-naive patients, at a median of 1.1 years after the survey. Survivors who had reported vaccine intent were more likely to initiate the vaccine and older survivors showed less likelihood for vaccine initiation. Findings thereby suggest the role of provider recommendation for the HPV vaccine in building intent, which then translates into subsequent initiation.